Showing results (221-230 of 279) with videos related to

Sort By:
Pageof 28
Blood Purification|September 18, 2018
Peritoneal Dialysis as an Option for Unplanned Dialysis Initiation in Patients with End-Stage Renal Disease and Diabetes MellitusHaijiao Jin, Zhaohui Ni, Xiajing Che, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|October 14, 2018
Number of Daily Peritoneal Dialysis Exchanges and Mortality Risk in a Chinese PopulationXueqing Yu, Jianghua Chen, Zhaohui Ni, et al.
Kidney International Reports|July 9, 2025
Randomized, Positive-Controlled Study on the Efficacy and Safety of Oral Polysaccharide-Iron Complex Therapy in Patients on HemodialysisRenhua Lu, Haijiao Jin, Juan Cao, et al.
Renal Failure|August 16, 2021
Leflunomide plus low-dose prednisone in patients with progressive IgA nephropathy: a multicenter, prospective, randomized, open-labeled, and controlled trialZhaohui Ni, Zhen Zhang, Zanzhe Yu, et al.
Free Radical Biology & Medicine|April 7, 2024
Activation of lipophagy is required for RAB7 to regulate ferroptosis in sepsis-induced acute kidney injuryYuanting Yang, Qisheng Lin, Xuying Zhu, et al.
Renal Failure|September 9, 2024
Prognosis of IgA nephropathy patient with proteinuria remission by supportive therapy: cohort from screening failed Chinese patients in TESTING studyYingman Guo, Sufang Shi, Jinghong Zhao, et al.
European Radiology|October 19, 2022
Texture analysis of native T1 images as a novel method for non-invasive assessment of heart failure with preserved ejection fraction in end-stage renal disease patientsTian-Yi Zhang, Dong-Aolei An, Hang Zhou, et al.
BMC Nephrology|December 6, 2022
The initial attempt at home hemodialysis in mainland ChinaZhaohui Ni, Yijun Zhou, Renhua Lu, et al.
Cellular and Molecular Life Sciences : CMLS|November 15, 2024
αKlotho modulates BNIP3-mediated mitophagy by regulating FoxO3 to decrease mitochondrial ROS and apoptosis in contrast-induced acute kidney injuryXuying Zhu, Qisheng Lin, Yuanting Yang, et al.
Clinical Therapeutics|August 7, 2024
HARMONIZE Asia: A Phase III Randomized Study to Investigate the Efficacy and Safety of Sodium Zirconium Cyclosilicate in Patients with Hyperkalemia in ChinaXinling Liang, Wanhong Lu, Xueqing Yu, et al.
Pageof 28